Statins lower cholesterol by blocking the enzyme your liver uses to produce it. They’re the most widely prescribed cholesterol-lowering drugs in the world, capable of reducing LDL (“bad”) cholesterol by 27% to 60% depending on the specific drug and dose. But cholesterol reduction is only part of the story. Statins also calm inflammation in blood vessel walls, stabilize dangerous plaques, and improve blood vessel function in ways that go beyond their effect on lipid numbers alone.
How Statins Lower Cholesterol
Your liver manufactures most of the cholesterol in your body, and the process starts with a single enzyme that acts as the bottleneck for the entire production line. Statins block that enzyme, binding to it with roughly 10,000 times more affinity than the molecule your body normally uses. This effectively shuts down the liver’s internal cholesterol factory.
What happens next is equally important. When liver cells sense their internal cholesterol supply dropping, they respond by producing more receptors on their surface that grab LDL particles out of the bloodstream. Those LDL particles get pulled into liver cells and processed into bile salts, which your body either excretes or recycles. The net result: less cholesterol being made, and more cholesterol being cleared from your blood.
How Much Cholesterol They Actually Lower
Not all statins are equally powerful. The degree of LDL reduction depends on which statin you take and at what dose. At the lower end, a moderate dose of pravastatin or lovastatin drops LDL by about 27%. At the high end, rosuvastatin at its maximum dose can cut LDL by roughly 60%. There’s a useful rule of thumb: doubling the dose of any statin only gets you about 6% more LDL reduction, which is why doctors sometimes switch to a stronger statin rather than simply increasing the dose.
Statins are grouped into three intensity tiers based on how much they lower LDL:
- Low-intensity (less than 30% LDL reduction): lower doses of simvastatin, pravastatin, lovastatin, or fluvastatin
- Moderate-intensity (30% to just under 50% reduction): the mid-range doses of most statins, including atorvastatin 10 to 20 mg and rosuvastatin 5 to 10 mg
- High-intensity (50% or greater reduction): only atorvastatin at 40 to 80 mg and rosuvastatin at 20 to 40 mg reach this level
Statins also raise HDL (“good”) cholesterol by about 5% to 10% and lower triglycerides. The triglyceride effect is especially notable if your levels are already high: someone starting with triglycerides above 250 mg/dL might see a 40% reduction, while someone with normal levels would see only about an 11% drop.
Effects Beyond Cholesterol
Some of the most important things statins do have nothing to do with your cholesterol numbers. They reduce inflammation throughout the cardiovascular system, which matters because inflammation drives much of the damage that leads to heart attacks and strokes. One major trial found that rosuvastatin reduced C-reactive protein, a key marker of cardiovascular inflammation, by 37%. This anti-inflammatory effect appears to be largely independent of cholesterol lowering.
Statins also improve the health of the inner lining of your blood vessels. They boost production of nitric oxide, a molecule that relaxes blood vessel walls, discourages blood clots from forming, and prevents the kind of cellular buildup that narrows arteries over time. These vascular benefits kick in relatively quickly and help explain why statins reduce cardiovascular events even in people whose cholesterol isn’t dramatically elevated.
What They Do to Existing Plaques
Perhaps the most compelling finding about statins is their ability to change plaques that have already formed inside your arteries. Plaques aren’t all the same. Some are soft and fatty with thin caps, making them prone to rupturing and triggering a heart attack. Others are more fibrous and calcified, essentially scar tissue that’s relatively stable.
Statins shift the composition of plaques in a favorable direction. Imaging studies using intravascular ultrasound have shown that high-intensity statin therapy reduces the fatty, necrotic core of plaques while increasing fibrous and calcified tissue. In practical terms, plaques become harder and more stable, less likely to crack open. One trial showed that patients on high-dose atorvastatin had zero progression of plaque volume over 18 months, while another demonstrated that high-dose rosuvastatin actually shrank plaques over two years. Additional research has confirmed that intensive statin therapy thickens the fibrous cap covering plaques, making rupture less likely.
How Quickly They Work
Statins don’t reach their full effect overnight. Your cholesterol levels begin dropping within the first few weeks, but the maximum LDL-lowering effect takes about three months regardless of which statin you’re on. That’s why doctors typically recheck your lipid panel around the three-month mark to see if the dose or drug needs adjusting. Plaque stabilization and regression take longer, with imaging studies typically measuring changes at 18 to 24 months of therapy.
Side Effects and Risks
Muscle symptoms are the most common complaint. In large randomized trials comparing statins to placebo, 27.1% of people on statins reported muscle pain or weakness, but so did 26.6% of people taking a placebo. That narrow gap (about half a percentage point) suggests that most muscle symptoms people experience while taking statins aren’t actually caused by the drug. This “nocebo effect,” where people develop symptoms because they expect them, is well documented with statins. Serious muscle damage is genuinely rare: roughly one extra case of significant muscle injury per 10,000 people per year, and only 2 to 3 cases of the most severe form per 100,000 people per year.
Statins do modestly increase the risk of developing type 2 diabetes. Low- or moderate-intensity therapy raises the risk by about 10%, while high-intensity therapy raises it by about 36%. This sounds alarming in percentage terms, but it needs context: the increase applies mostly to people who are already on the path toward diabetes, with prediabetic blood sugar levels or other risk factors. For people at significant cardiovascular risk, the reduction in heart attacks and strokes substantially outweighs the diabetes risk.
Liver Monitoring
Statins were once thought to require regular liver function testing, but guidelines have shifted considerably. Current recommendations call for a single liver test before starting a statin. After that, routine repeated testing isn’t necessary unless symptoms develop. The FDA dropped its requirement for periodic liver monitoring back in 2012, and UK guidelines similarly moved away from routine annual testing. Clinically significant liver injury from statins is extremely uncommon.
How Statins Fit Into Cardiovascular Prevention
Statins work on multiple fronts simultaneously: lowering cholesterol production, pulling LDL out of the bloodstream, calming vascular inflammation, improving blood vessel function, and transforming dangerous plaques into stable ones. This combination of effects is why they remain the cornerstone of cardiovascular prevention despite decades of newer drugs entering the market. The benefits are dose-dependent, meaning higher-intensity therapy produces greater plaque regression and larger reductions in cardiovascular events, though this needs to be balanced against the slightly higher risk of side effects like new-onset diabetes at higher doses.